The new panel is designed to identify women who are diagnosed with ER+ breast cancer but do not respond to hormone therapy
The centre aims to trial new approaches in treating ovarian cancer and expand research into new therapies
The combination has been shown to stimulate the body’s immune system and kill off cancer cell growth
Companies could benefit from new breast screening recommendations, shows data
The trial is set to run in Walsall, Sandwell and Birmingham for 18 months
Only one in two women were able to recognise persistent pain and bloating as signs of ovarian cancer in new survey
Israeli researchers tested the new drug and achieved a survival rate of 80 per cent
The submission is supported by data from more than 700 breast cancer patients across five clinical studies
Women identified as at risk will be invited for check-ups over the next 12 months
Proceeds from the financing will be used to advance the development and commercialisation of a lung cancer screening test
